Study finds different barriers at different stages of care
Breast cancer diagnosed before age 40 presents a difficult clinical problem: many patients are below the age at which routine screening is generally recommended, yet the disease can carry a poor prognosis and distinct treatment and psychosocial challenges. A new analysis of young women with breast cancer found that delays can occur before a patient first seeks care, during the path to diagnosis, and after diagnosis before treatment begins.
The analysis, published online in Cancer, used data from 1,071 people enrolled in the Young Women’s Breast Cancer Study. That multisite prospective cohort follows women diagnosed with breast cancer by age 40. Investigators examined how patient and tumor characteristics related to delays in care and how those delays related to cancer stage.
The findings point to a pattern rather than a single failure point. Lower annual income was associated with greater odds of a delay in presenting symptoms to a clinician. Younger patients had higher odds of a delay in diagnosis after they had already sought care. The analysis also found that women who experienced diagnostic delays were more likely to have late-stage disease.
How the researchers defined delay
The study separated the route from symptoms to treatment into three intervals. A presentation delay meant 90 days or more between the first patient-reported symptoms and presentation to a clinician. A diagnostic delay meant 90 days or more between the first healthcare visit for symptoms and a biopsy that resulted in a breast-cancer diagnosis. A treatment delay meant 60 days or more between diagnosis and the first treatment.
Using these thresholds, the researchers identified 153 presentation delays, 120 diagnostic delays and 228 treatment delays among the participants. Those figures show why simply measuring the time from diagnosis to treatment does not capture the whole experience of younger patients. The earliest delay can occur before a health professional has assessed the symptoms, while another can arise after a patient has already entered the healthcare system.
Because the participants were diagnosed by age 40, the research addresses a group that may be less likely to undergo routine screening. The source report notes that younger women may also encounter assumptions that they are too young to have breast cancer, which can affect how quickly symptoms are acted on or investigated.
Income, age and tumor characteristics
After accounting for influencing factors, lower annual income was linked to higher odds of presentation delay. The study also found lower odds of presentation delay among patients who were pregnant at diagnosis, had a family history of breast cancer or had triple-negative breast cancer.
For diagnostic delay, age mattered: younger patients had higher odds of delay. Patients with triple-negative tumors had lower odds of diagnostic delay. The analysis further associated diagnostic delay with a greater likelihood of late-stage disease.
The relationship between delay and disease stage was not identical across every form of breast cancer. Presentation delays were associated with later-stage disease in women with certain HER2-positive tumors. That distinction underscores the importance of looking beyond a single overall average when studying care pathways and cancer outcomes.
What the findings mean
The study does not establish that any one factor causes a delay for an individual patient. It identifies associations in a prospective cohort of people diagnosed with breast cancer at or before age 40. Still, the findings indicate that efforts to shorten time to care may need to address distinct challenges at different stages.
At the presentation stage, the association with lower income points to the importance of barriers that may affect whether and when a person can seek clinical assessment after noticing symptoms. At the diagnostic stage, the association with younger age highlights the challenge of recognizing breast-cancer symptoms in people who fall below the usual screening age. Once a diagnosis has been made, the study’s separate treatment-delay measure offers a way to examine the next step in the pathway rather than treating diagnosis as the end of the process.
For patients and clinicians, the research reinforces that breast cancer can occur in younger adults and that symptoms warrant timely clinical attention. The results are population-level findings, not a guide to an individual diagnosis or treatment plan. Decisions about symptoms, testing and treatment should be made with qualified healthcare professionals.
A fuller view of timely cancer care
The Young Women’s Breast Cancer Study analysis frames timely care as a sequence: noticing symptoms, reaching a clinician, obtaining a biopsy-based diagnosis and beginning treatment. Its results suggest that interventions designed for only one part of that sequence may miss other points where delays arise.
By documenting 153 presentation delays, 120 diagnostic delays and 228 treatment delays in a cohort of 1,071 participants, the researchers provide a more granular view of the obstacles facing young people with breast cancer. The association of diagnostic delay with later-stage disease gives added urgency to improving recognition and evaluation of concerning symptoms in this population.
Future work will be needed to determine which changes most effectively reduce delays, particularly for patients facing economic barriers and for younger people whose symptoms may not immediately prompt suspicion of breast cancer. For now, the study adds evidence that age and income can shape the journey from symptoms to treatment.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
